• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有不同连接键的蒽环类药物-GnRH 衍生物生物缀合物:合成、体外药物释放和细胞抑制作用。

Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect.

机构信息

Laboratory of Analytical Chemistry and Biopolymer Structure Analysis, Department of Chemistry, University of Konstanz, 78457 Konstanz, Germany.

出版信息

J Control Release. 2011 Dec 10;156(2):170-8. doi: 10.1016/j.jconrel.2011.08.005. Epub 2011 Aug 12.

DOI:10.1016/j.jconrel.2011.08.005
PMID:21864594
Abstract

To increase the selectivity and consequently to minimize the side effects of chemotherapeutic agents, receptor mediated tumor targeting approaches have been developed. In the present work, various anthracycline-GnRH derivative bioconjugates were synthesized with the aim of investigating the influence of (i) different anthracycline anticancer drugs, (ii) different linkages between the targeting moiety and the anticancer drug, and (iii) different targeting moieties (e.g., GnRH-III and [D-Lys⁶]-GnRH-I) on their in vitro drug release and cytostatic effect. The anthracyclines, daunorubicin or doxorubicin, were attached to the ε-amino group of Lys of GnRH-III or [D-Lys⁶]-GnRH-I through oxime, hydrazone or ester bonds. In another bioconjugate, a self-immolative p-aminobenzyloxycarbonyl spacer was used to link daunorubicin to GnRH-III. The in vitro degradation of the bioconjugates was investigated in the presence of rat liver lysosomal homogenate and cathepsin B. The cellular uptake of the compounds was evaluated by flow cytometry and their in vitro cytostatic effect was determined by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide assay. The results indicate that on the tested cancer cell lines there is no significant difference in the cellular uptake and in vitro cytostatic effect of bioconjugates containing GnRH-III or [D-Lys⁶]-GnRH-I as a targeting moiety. The bioconjugates containing ester bond, hydrazone bond and the self-immolative spacer exert the highest cytostatic effect, followed by oxime bond-linked compounds.

摘要

为了提高选择性,从而最大限度地减少化疗药物的副作用,已经开发了受体介导的肿瘤靶向方法。在本工作中,合成了各种蒽环类药物-GnRH 衍生物缀合物,目的是研究(i)不同的蒽环类抗癌药物、(ii)靶向部分与抗癌药物之间的不同连接、和(iii)不同的靶向部分(例如,GnRH-III 和 [D-Lys⁶]-GnRH-I)对其体外药物释放和细胞抑制作用的影响。通过肟、腙或酯键,将蒽环类药物柔红霉素或阿霉素连接到 GnRH-III 或 [D-Lys⁶]-GnRH-I 的 Lys 的 ε-氨基上。在另一种缀合物中,使用自毁的对氨基苄氧羰基间隔物将柔红霉素连接到 GnRH-III。在存在大鼠肝溶酶体匀浆和组织蛋白酶 B 的情况下,研究了缀合物的体外降解情况。通过流式细胞术评估了化合物的细胞摄取,并通过 3-(4,5-二甲基噻唑基-2)-2,5-二苯基四氮唑溴盐测定法测定了它们的体外细胞抑制作用。结果表明,在所测试的癌细胞系中,含有 GnRH-III 或 [D-Lys⁶]-GnRH-I 作为靶向部分的缀合物的细胞摄取和体外细胞抑制作用没有显著差异。含有酯键、腙键和自毁间隔物的缀合物表现出最高的细胞抑制作用,其次是肟键连接的化合物。

相似文献

1
Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect.具有不同连接键的蒽环类药物-GnRH 衍生物生物缀合物:合成、体外药物释放和细胞抑制作用。
J Control Release. 2011 Dec 10;156(2):170-8. doi: 10.1016/j.jconrel.2011.08.005. Epub 2011 Aug 12.
2
In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites.肟键连接的柔红霉素-GnRH-III 生物缀合物的体外降解和抗肿瘤活性及柔红霉素-氨基酸代谢物的 DNA 结合特性。
Amino Acids. 2011 Jul;41(2):469-83. doi: 10.1007/s00726-010-0766-1. Epub 2010 Oct 16.
3
Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4.4 位修饰的柔红霉素-GnRH-III 生物缀合物的酶稳定性和抗肿瘤活性增强
Bioconjug Chem. 2011 Jul 20;22(7):1320-9. doi: 10.1021/bc100547p. Epub 2011 Jun 23.
4
GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate.基于 GnRH-III 的载多柔比星和甲氨蝶呤的多功能药物传递系统。
Eur J Med Chem. 2012 Jun;52:173-83. doi: 10.1016/j.ejmech.2012.03.016. Epub 2012 Mar 16.
5
Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.短链脂肪酸酰化柔红霉素-GnRH-III 生物缀合物增强了细胞摄取和体外抗肿瘤活性。
Eur J Med Chem. 2012 Oct;56:155-65. doi: 10.1016/j.ejmech.2012.08.014. Epub 2012 Aug 23.
6
Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug.一种含肟键的柔红霉素-促性腺激素释放激素III缀合物作为潜在抗癌药物的研发。
Bioconjug Chem. 2009 Apr;20(4):656-65. doi: 10.1021/bc800542u.
7
Modification of daunorubicin-GnRH-III bioconjugates with oligoethylene glycol derivatives to improve solubility and bioavailability for targeted cancer chemotherapy.用聚乙二醇衍生物修饰柔红霉素 - 促性腺激素释放激素III生物共轭物以提高其溶解度和生物利用度用于靶向癌症化疗。
Biopolymers. 2015 May;104(3):167-77. doi: 10.1002/bip.22629.
8
Synthesis, enzymatic stability and in vitro cytostatic effect of Daunorubicin-GnRH-III derivative dimers.达柔比星-GnRH-III 衍生物二聚体的合成、酶稳定性和体外细胞抑制作用。
Bioorg Med Chem Lett. 2013 Apr 1;23(7):2145-50. doi: 10.1016/j.bmcl.2013.01.114. Epub 2013 Jan 31.
9
Design, synthesis, in vitro stability and cytostatic effect of multifunctional anticancer drug-bioconjugates containing GnRH-III as a targeting moiety.含GnRH-III作为靶向部分的多功能抗癌药物生物共轭物的设计、合成、体外稳定性及细胞抑制作用
Biopolymers. 2012;98(1):1-10. doi: 10.1002/bip.21640. Epub 2011 Apr 20.
10
Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor.肟键连接的柔红霉素-GnRH-III 生物缀合物通过 I 型 GnRH 受体在去势抵抗性前列腺癌细胞中发挥抗肿瘤活性。
Int J Oncol. 2015 Jan;46(1):243-53. doi: 10.3892/ijo.2014.2730. Epub 2014 Oct 24.

引用本文的文献

1
Advances and Challenges in Structural Studies of Bioactive Peptide-Anthracycline Conjugates: A Mass Spectrometric Insight.生物活性肽-蒽环类药物缀合物结构研究的进展与挑战:质谱学视角
Int J Mol Sci. 2025 May 20;26(10):4896. doi: 10.3390/ijms26104896.
2
Michael Acceptors as Anti-Cancer Compounds: Coincidence or Causality?迈克尔受体作为抗癌化合物:巧合还是必然?
Int J Mol Sci. 2024 Jun 1;25(11):6099. doi: 10.3390/ijms25116099.
3
Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
肟连接肽-柔红霉素缀合物作为在靶向肿瘤治疗中选择合适归巢装置的良好工具:概述。
Int J Mol Sci. 2024 Feb 3;25(3):1864. doi: 10.3390/ijms25031864.
4
Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide-Drug Conjugates.靶向胃泌素释放肽受体(GRP-R)在癌症治疗中的应用:基于蛙皮素的肽药物偶联物的开发。
Int J Mol Sci. 2023 Feb 8;24(4):3400. doi: 10.3390/ijms24043400.
5
Influence of the Drug Position on Bioactivity in Angiopep-2-Daunomycin Conjugates.载药位置对 Angiopep-2-柔红霉素偶联物生物活性的影响。
Int J Mol Sci. 2023 Feb 4;24(4):3106. doi: 10.3390/ijms24043106.
6
Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates.含 GnRH-III-药物偶联物的自毁性连接子的开发和生化特性研究。
Int J Mol Sci. 2022 May 3;23(9):5071. doi: 10.3390/ijms23095071.
7
Peptide-Drug Conjugates with Different Linkers for Cancer Therapy.具有不同连接子的用于癌症治疗的肽-药物偶联物。
J Med Chem. 2021 Jan 14;64(1):216-232. doi: 10.1021/acs.jmedchem.0c01530. Epub 2020 Dec 31.
8
Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions.前列腺癌中的促性腺激素释放激素受体:分子方面和生物学功能。
Int J Mol Sci. 2020 Dec 14;21(24):9511. doi: 10.3390/ijms21249511.
9
Improving the Stability of Maleimide-Thiol Conjugation for Drug Targeting.提高马来酰亚胺-巯基偶联物用于药物靶向的稳定性。
Chemistry. 2020 Dec 4;26(68):15867-15870. doi: 10.1002/chem.202003951. Epub 2020 Oct 27.
10
Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs.促性腺激素释放激素类似物治疗乳腺癌
Front Oncol. 2019 Oct 1;9:943. doi: 10.3389/fonc.2019.00943. eCollection 2019.